An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Irinotecan (CPT-11) and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Alvocidib (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Biomarker
- 01 Apr 2008 The expected completion date for this trial is now 1 May 2009, from clinicaltrials.gov record.
- 24 Aug 2005 New trial record.